exRNAdisease

Entry Detail

---



General Information

Database ID: exR0357072 RNA Name: hsa-miR-424-5p RNA Type: miRNA Chromosome: chrX Starnd: - Coordinate: Start Site(bp): 134546680 End Site(bp): 134546701 External Links: hsa-miR-424-5p

Disease Information

Disease Name: Breast Cancer Disease Category: Cancers MeSH ID: D001943 Type: Neoplasms/Breast Neoplasms Alias: Breast Neoplasms//Breast Neoplasm//Neoplasm, Breast//Breast Tumors//Breast Tumor//Tumor, Breast//Tumors, Breast//Neoplasms, Breast//Breast Cancer//Cancer, Breast//Mammary Cancer//Cancer, Mammary//Cancers, Mammary//Mammary Cancers//Malignant Neoplasm of Breast//Breast Malignant Neoplasm//Breast Malignant Neoplasms//Malignant Tumor of Breast//Breast Malignant Tumor//Breast Malignant Tumors//Cancer of Breast//Cancer of the Breast//Mammary Carcinoma, Human//Carcinoma, Human Mammary//Carcinomas, Human Mammary//Human Mammary Carcinomas//Mammary Carcinomas, Human//Human Mammary Carcinoma//Mammary Neoplasms, Human//Human Mammary Neoplasm//Human Mammary Neoplasms//Neoplasm, Human Mammary//Neoplasms, Human Mammary//Mammary Neoplasm, Human//Breast Carcinoma//Breast Carcinomas//Carcinoma, Breast//Carcinomas, Breast

Expression Detail

GEO ID: GSE98181 Description: Circulating miRNA profiles from serum of women at high-risk for breast cancer Experimental Design: Cancer vs Control Case Disease Type: Breast Cancer Case Disease SubType: NA Case Sample: Breast Cancer Control Sample: Healthy Number of Case: 24 Number of Control: 24 Number of Samples: 48

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AADAT chr4 170060222 170091699 - ARRDC4 chr15 97960703 97973833 + ASB1 chr2 238426742 238452250 + ATXN2L chr16 28823035 28837237 + BACE1 chr11 117285207 117316259 - CASZ1 chr1 10636604 10796650 - DCAF7 chr17 63550477 63594279 + FAM102B chr1 108560089 108644900 + FLOT2 chr17 28879335 28897733 - JADE2 chr5 134524312 134583230 + KDSR chr18 63327726 63367228 - LITAF chr16 11547722 11636381 - LY6E chr8 143017982 143023832 + MAPKBP1 chr15 41774434 41827855 + MED11 chr17 4731428 4733607 + MINDY2 chr15 58771192 58861900 + MRPS2 chr9 135499984 135504673 + MYB chr6 135181308 135219173 + PRKAA1 chr5 40759379 40798374 - RAPGEF1 chr9 131576770 131740074 - RET chr10 43077064 43130351 + RTL8B chrX 135020513 135022542 - STEAP3 chr2 119223831 119265652 + TOB2 chr22 41433494 41446801 - ZNF664 chr12 123971845 124015439 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000540 chr14 55799534 55821940 + hsa_circ_0001005 chr2 53921020 53978078 - hsa_circ_0001723 chr7 91924202 91948826 + hsa_circ_0000458 chr12 124071293 124074996 + hsa_circ_0001699 chr7 40027197 40041630 + hsa_circ_0001387 chr4 1902352 1936989 + hsa_circ_0001168 chr20 47691321 47707559 + hsa_circ_0000552 chr14 71880664 71948928 + hsa_circ_0000038 chr1 28800065 28802803 + hsa_circ_0000652 chr15 90984737 90986710 + hsa_circ_0001472 chr5 36953719 36976504 + hsa_circ_0001263 chr3 5215701 5216099 + hsa_circ_0000799 chr17 65941524 65972074 + hsa_circ_0001164 chr20 45891031 45923523 - hsa_circ_0000032 chr1 25666964 25669564 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand NUTM2A-AS1 chr10 87201647 87342612 - LINC02035 chr3 122886941 122892416 + AC002470.2 chr22 20979462 20998121 + AC021092.1 chr19 44103007 44113183 - MCM3AP-AS1 chr21 46229196 46259390 + LINC00662 chr19 27681072 27794005 - MIR503HG chrX 134543119 134546642 - MIR497HG chr17 7015818 7019659 - AC079781.5 chr7 97851688 97972985 - STAG3L5P-PVRIG2P-PILRB chr7 100336104 100367831 + SNHG12 chr1 28578538 28583132 - AC009022.1 chr16 69976297 70065948 - LINC00649 chr21 33915534 33977691 + AP000317.2 chr21 34073592 34360033 + AL359924.1 chr1 237862175 237928321 + AC114980.1 chr5 93860669 93863825 - FGD5-AS1 chr3 14920347 14948424 - AL031282.2 chr1 1702736 1737688 - NUTM2B-AS1 chr10 79661394 79826594 - AL391244.1 chr1 1420245 1422691 + LINC01184 chr5 127939152 128083172 - XIST chrX 73820649 73852723 - HCG18 chr6 30286690 30327382 - SNHG16 chr17 76557764 76565348 + SNHG25 chr17 64145970 64146476 + SNHG1 chr11 62851984 62855953 - AC020978.7 chr16 68224713 68227734 + MZF1-AS1 chr19 58559129 58574797 + MIR29B2CHG chr1 207801518 207879115 - AC003092.1 chr7 94022833 94066661 + Display:

Experiment Detail

GEO ID: GSE98181 Sample Source: Blood Source Fraction: Serum Platform: GPL21572 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2546 Sample treatment protocol: Serum is obtained from coagulated whole blood samples by centrifugation at 3000 rpm for 10 minutes. RNA Extract protocol: RNA was isolated from a 200ul serum aliquot using the miRNeasy Serum Plasma kit with ce-miR-39 spike-in (QIAGEN), QIAcube (QIAGEN) automation, and eluted with 14uL of nuclease-free water. RNA library preparation protocol: Exactly 8ul of RNA was tagged with a Poly-A tail, using an ATP driven reaction from the Affymetrix® FlashTag™ Biotin HSR RNA Labeling Kit.

Reference

PMID: 29348816 Title: Development of a predictive miRNA signature for breast cancer risk among high-risk women. Author: Farina NH, Ramsey JE, Cuke ME, Ahern TP, Shirley DJ, Stein JL, Stein GS, Lian JB, Wood ME Journal: Oncotarget. 2017 Nov 28;8(68):112170-112183. Description: We evaluated the ability of C-miRNAs to identify women most likely to develop breast cancer by profiling miRNA from serum obtained long before diagnosis.